Literature DB >> 25352839

Occurrence of virulence factors and antimicrobial resistance in Pasteurella multocida strains isolated from slaughter cattle in Iran.

Faham Khamesipour1, Hassan Momtaz2, Morteza Azhdary Mamoreh3.   

Abstract

A total of 30 Pasteurella multocida strains isolated from 333 pneumonic and apparently health slaughter cattle were examined for capsule biosynthesis genes and 23 virulence-associated genes by polymerase chain reaction (PCR). The disc diffusion technique was used to determine antimicrobial resistance profiles among the isolates. Of the isolates, 23 belonged to capsular type A, 5 to capsular type D and two isolates were untypeable. The distribution of the capsular types in pneumonic lungs and in apparently health lungs was statistically similar. All virulence genes tested were detected among the isolates derived from pneumonic lungs; whereas isolates derived from apparently health lungs carried 16 of the 23 genes. The frequently detected genes among isolates from pneumonic lungs were exbD, hgbA, hgbB, ompA, ompH, oma87, and sodC; whereas tadD, toxA, and pmHAS genes occurred less frequently. Most of the adhesins and superoxide dismutases; and all of the iron acquisition and protectin proteins occurred at significantly (p ≤ 0.05) higher frequencies in isolates from pneumonic lungs. Isolates from apparently healthy lungs didn't carry the following genes; hsf-1, hsf-2, tadD, toxA, nanB, nanH, and pmHAS. One adhesion (hsf-1) and two iron acquisition (exbD and tonB) genes occurred at significantly (p ≤ 0.05) higher frequencies among capA isolates. All the P. multocida isolates were susceptible to ciprofloxacin, co-trimoxazole, doxycycline, enrofloxacin, nitrofurantoin, and tetracyclines. Different proportions of the isolates were however resistant to ampicillin, amoxicillin, erythromycin, lincomycin, penicillin, rifampin, streptomycin, and florfenicol. Our results reveal presence of virulence factors (VFs) in P. multocida strains isolated from symptomatic and asymptomatic bovids. A higher frequency of the factors among isolates from symptomatic study animals may suggest their role in pathogenesis of P. multocida-associated bovine respiratory disease (BRD). The results further reveal occurrence of antimicrobial resistance among some isolates. Control strategies for this pathogen, which could include development of an effective vaccine, are warranted so as to mitigate the social and economic consequences attributable to natural infections with this bacterium.

Entities:  

Keywords:  Iran; Pasteurella multocida; antimicrobial resistance; cattle; virulence factors

Year:  2014        PMID: 25352839      PMCID: PMC4196553          DOI: 10.3389/fmicb.2014.00536

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


Introduction

Cattle rearing is one of the important sources of income in Iran, involving both dairy and beef breeds. The sector faces a number of constraints ranging from limited feed resources to diseases. Of the diseases, those caused by infectious agents are of great importance which include bacteria and viruses affecting the respiratory system (Hemmatzadeh et al., 2001; Haji Hajikolaei and Seyfi Abad Shapouri, 2007; Sakhaee et al., 2009). The most important bacteria that play a role in pneumonia include: Mannheimia haemolytica, Pasteurella multocida, and Haemophilus somnus pneumonia, which presence of these bacteria in pneumonia lesions of slaughtered cattle around Iran have also been reported (Haji Hajikolaei et al., 2010). Bovine respiratory disease (BRD) is a significant cause of morbidity and mortality among beef cattle in the world (Dagleish et al., 2010; Hotchkiss et al., 2010; Portis et al., 2012). Among others, Pasteurella multocida has been identified as a major bacterial etiologic agent for this disease (Confer, 2009; Griffin et al., 2010). It is a zoonotic Gram negative bacterium responsible for a range of infections in domestic animals causing substantial economic losses (Steen et al., 2010). The organism causes fowl cholera in domestic and wild birds, bronchopneumonia and hemorrhagic septicemia in bovids, atrophic rhinitis in porcines and snuffles in rabbits (Mannheim, 1984; Hunt et al., 2000). Most human infections with P. multocida result from dog and cat bites, but infections through the respiratory tract may also occur (Hubbert and Rosen, 1970). Several host and pathogen-specific attributes do determine the outcome of infections caused by P. multocida (Verma et al., 2013). Of the pathogen factors important ones include the capsular and virulence-associated genes (Katsuda et al., 2013). These virulence factors (VFs) and outer membrane proteins are important for pathogenesis, functionality, protective immunity and vaccine development against P. multocida infections (Harper et al., 2006; Hatfaludi et al., 2010). Based on capsular antigens, P. multocida strains are differentiated into five serogroups i.e., type A causing fowl cholera pathogen and bovine shipping fever, type B causing hemorrhagic fever in ungulates, type D causing atrophic rhinitis in swine, type E, an African serotype, infecting cattle and buffalo; and type F also causing fowl cholera (Carter, 1955, 1961, 1967; Rimler and Rhoades, 1987). Virulence associated genes described for P. multocida isolates and their examples include adherence and colonization factors (ptfA, fimA, hsf-1, hsf-2, pfhA, and tadD), iron-regulated and acquisition proteins(exbB, exbD, tonB, hgbA, hgbB, and Fur), extracellular enzymes such as neuraminidase (nanB and nanH), hyaluronidase (pmHAS) and superoxide dismutases (soda, sodC, and tbpA), toxins (toxA), lipopolysaccharides (LPS), capsule and a variety of outer membrane proteins such as protectins (ompA, omph, oma87, and plpB) (Katoch et al., 2014). Increased use of antibiotics in modern animal production has been associated with emergence of antimicrobial resistant bacteria with potential for transfer of resistance from animals to humans (Witte, 1998). As a result, antimicrobial resistance among bacterial pathogens has of recent become a big problem in both the veterinary and human medicine fields (Levy, 1998; Caprioli et al., 2000; Kehrenberg et al., 2001; White et al., 2002; Shea, 2003). The implication of the problem is increased treatment cost, prolonged illness due to treatment failure and sometimes death (Kelly et al., 2004). The present study was conducted with the aim to detect the occurrence of VFs in P. multocida isolated from pneumonic and apparently health lungs of slaughter cattle in Iran. It was also to determine the occurrence of antimicrobial resistance among the isolates.

Materials and methods

Sample collection

A total of 333 samples, from both pneumonic (219) and apparently healthy (114) lungs, were collected randomly from slaughter cattle in an industrial abattoir in Shahrekord province during the period of September 2013 to March 2014. The abattoir receives cattle from different herds within and outside the province. For the purpose of this study pneumonic lungs referred to those lungs with gross lesions such as consolidation, fibrin deposition on the pleura, pleurisy, and/or adhesion; and apparently healthy lungs was used to describe those lungs without gross lesions. A simple random procedure was used to select pre-identified pneumonic and apparently health lungs. Random numbers were generated in Microsoft excel®. Specimens were obtained aseptically using a sterile scalpel while taking precautions to prevent surface contamination. Following collection the samples were conveyed to the microbiology laboratory in special ice-filled containers within 6 h of sampling.

P. multocida screening

Isolation of P. multocida was done using techniques described previously by other authors (Songer and Post, 2005). Briefly, swabs were obtained from the collected samples and were plated on tryptic soy agar (Difco, Detroit, MI) containing 10 μg/ml NAD (Sigma, St. Louis, MO) and 5% bovine serum, MacConkey agar, and blood agar (5% fresh sheep blood). All plates were incubated at 37°C in air for a minimum of 48 h.

Identification of isolates

Preliminary identification of P. multocida isolates was carried out according to standard biochemical tests as described earlier (Songer and Post, 2005). The isolates were gram-negative coccobacilli and were indole, catalase and oxidase-positive. But, citrate, Methyl red (MR), Vogaes–Proskauer (VP), and gelatin liquefaction negative. They don't grow on MacConkey agar and do not show hemolysis on blood agar. Confirmation of the isolates was done by polymerase chain reaction (PCR) assay with primers specific for the amplification of the KMT1 gene, adopting the methodology previously described by Townsend et al. (1998). All confirmed isolates of P. multocida were subsequently characterized by capsular serotyping using PCR. Primers for amplification of hyaD-hyaC and DcbF genes were used for detection of capsular type A and capsular type D, respectively (Table 1). P. multocida isolates which didn't yield bands on PCR when the two primers were used were classified as untyped. Following confirmation and characterization all isolates were freeze-dried and kept at −20°C.
Table 1

Primers used for the detection of serogroups in strains of .

SerogroupGenePrimer namePrimer sequence (5′–3′)Amplic size (bp)Anneal. Temp (°C)Reference
AllKMT1KMT1T7 KMT1SP6ATCCGCTATTTACCCAGTGG GCTGTAAACGAACTCGCCAC46055Townsend et al., 1998
Capsular type AhyaD-hyaCCAPA-F CAPA-RCATTTATCCAAGCTCCACC GCCCGAGAGTTTCAATCC76055
Capsular type DDcbFCAPD-F CAPD-RTTACAAAAGAAAGACTAGGAGCCC CATCTACCCACTCAACCATATCAG65755
Primers used for the detection of serogroups in strains of .

Detection of virulence genes

The virulence genes of P. multocida isolates were detected by PCR. They included adhesins (ptfA, fimA, hsf-1, hsf-2, pfhA, and tadD), toxin (toxA), iron acquisition (exbB, exbD, tonB, hgbA, hgbB, and Fur), sialidases (nanB and nanH), hyaluronidase (pmHAS), protectins (ompA, omph, oma87, and plpB) and superoxide dismutases (soda, sodC, and tbpA) (Table 2). The base sequences and the predicted sizes of the amplified products for the specific oligonucleotide primers used in detection of the genes in this study are shown in Table 3. The bacterial lysates used as templates for the PCR were prepared as follows. A loopful of bacteria from a fresh overnight culture on a tryptic soy agar plate was resuspended homogeneously in 200 μl of sterile water, and the mixture was boiled at 100°C for 5 min to release the DNA and centrifuged. A 4 μl volume of the supernatant was used as a template for each 25 μl PCR mixture. The amplified products were analyzed in 1% agarose gels by electrophoresis, and the results were recorded with a gel documentation system. All tests were repeated three times in parallel with the relevant positive (P. multocida strains ATCC 15742, ATCC 12945, and ATCC 12946) and negative (distilled water) controls. Discrepant results for each VF were investigated further, and samples were sequenced for gene verification.
Table 2

Tested virulence-associated genes in strains of .

Gene function and geneDescription
ADHESINS
ptfAType 4 fimbriae
fimAFimbriae (from Pm70)
hsf-1Autotransporter adhesion (from Pm70)
hsf-2Autotransporter adhesion (from Pm70)
pfhAFilamentous hemagglutinin
tadDPutative non-specific tight adherence protein D
toxADermonecrotic toxin
exbBAccessory protein Ton-dependent transport of iron compounds
exbDAccessory protein Ton-dependent transport of iron compound
tonBIron transporters, transport ferric-siderophore complexes
hgbAA hemoglobin-binding protein
hgbBB hemoglobin-iron uptake
FurFerric uptake regulation protein
SIALIDASES nanB
nanBOuter membrane-associated proteins, an autotransporter protein
nanHOuter membrane-associated proteins, small sialidases
HYALURONIDASE
pmHASHyaluronan synthase
SUPEROXIDE DISMUTASE
sodASuperoxide dismutase
sodCSuperoxide dismutase
tbpASuperoxide dismutase
PROTECTINS
ompAOuter membrane protein A
ompHOuter membrane protein H
oma87Outer membrane protein 87
plpBLipoprotein B
Table 3

Primers used for the detection of virulence-associated genes in strains of .

Gene function and genePrimer sequence (5′–3′)Amplicon size (bp)Annealing temp (°C)References
ADHESINS
ptfATGTGGAATTCAGCATTTTAGTGTGTC TCATGAATTCTTATGCGCAAAATCCT GCTGG48855Townsend et al., 1998
fimACCATCGGATCTAAACGACCTA AGTATTAGTTCCTGCGGGTG86655
hsf-1TTGAGTCGGCTGTAGAGTTCG ACTCTTTAGCAGTGGGGACAACCTC65454
hsf-2ACCGCAACCATGCTCTTAC TGACTGACATCGGCGGTAC43354
pfhATTCAGAGGGATCAATCTTCG AACTCCAGT TGGTTTGTCG28655
tadDTCTACCCATTCTCAGCAAGGC ATCATTTCGGGCATTCACC41655
TOXINS
toxACTTAGATGAGCGACAAGG GAATGCCACACCTCTATAG86455Townsend et al., 1998
SUPEROXIDE DISMUTASE
sodATACCAGAATTAGGCTACGC GAAACGGGTTGCTGCCGCT36155Ewers et al., 2006
tbpATTGGTTGGAAACGGTAAAGC TAACGTGTACGGAAAAGCCC72854
sodCAGTTAGTAGCGGGGTTGGCA TGGTGCTGGGTGATCATCATG23555Lainson et al., 1996
SIALIDASES nanB
nanBCATTGCACCTAACACCTCT GGACACTGATTGCCCTGAA55555Townsend et al., 1998
nanHGTGGGAACGGGAATTGTGA ACATGCCAAGTTTGCCCTA28755
PROTECTINS
ompACGCATAGCACTCAAGTTTCTCC CATAAACAGATTGACCGAAACG20155Townsend et al., 1998
ompHCGCGTATGAAGGTTTAGGT TTTAGATTGTGCGTAGTCAAC43855
oma87GGCAGCGAGCAACAGATAACG TGTTCGTCAAATGTCGGGTGA83855
plpBTTTGGTGGTGCGTATGTCTTCT AGTCACTTTAGATTGTGCGTAG28255
HYALURONIDASE
pmHASTCAATGTTTGCGATAGTCCGTTAG TGGCGAATGATCGGTGATAGA43054Townsend et al., 1998
IRON ACQUISITION
exbBTTGGCTTGTGATTGAACGC TGCAGGAATGGCGACTAA A28355Townsend et al., 1998
exbDCGTTCTGATTACAGCCTCTT AACGAAATCTTGGAAACTGG24755
tonBCGACGGTGAAACCTGAGCCA CCGAGCGATAAGCATTGACT26155
hgbATCAACGGCAGATAATCAGGG GCGGGAATGCTGAAGATAAG26755
FurGTTTACCGTGTATTAGACCA CATTACTACATTTGCCATAC24455
hgbBACCGCGTTGGAATTATGATTG CATTGAGTACGGCTTGACAT78855Ewers et al., 2006
Tested virulence-associated genes in strains of . Primers used for the detection of virulence-associated genes in strains of .

Antimicrobial resistance test

Antimicrobial resistance profiles of the isolates to 20 antimicrobial agents were determined by the disc diffusion method on Muller Hinton agar with 5% blood (Carter and Subronto, 1978). The plates were inoculated with a cotton swab dipped into a 0.5 McFarland standard suspension of each isolates, according to the procedures outline in NCCLS (NCCLS, 2008). Then, the plates were incubated at 37°C for 24 h. The inhibition zones around each disc were measured and interpretation of results made according to the guidelines provided by manufacturers (Pattan-Teb, Tehran, Iran) and those provided by NCCLS (2008). The results were interpreted as resistant (R), intermediate (I), and susceptible (S).

Statistical data analysis

Data analysis was performed in SPSS software version 12.0 (SPSS Inc., Chicago, IL). Descriptive statistics were computed to determine the proportions of the different VFs among the isolates; and proportions of isolates resistant to different antimicrobial agents. Chi square test adopted for determination of statistical significance of differences between the proportions.

Results

Prevalence of P. multocida in collected samples

The prevalence of P. multocida in collected lung samples is indicated in Table 4. Overall 9.0% (30/333) of the sampled cattle were infected with the organism. The frequency of infection with the organism was higher in pneumonic lungs than in apparently health lungs and the difference was statistically significant at p ≤ 0.05.
Table 4

Prevalence of .

Lung samplesNumber of samplesNumber of positive samples
Pneumonic lungs21925 (11.4%)
Healthy lungs1145 (4.4%)
Total33330 (9.0%)
Prevalence of .

Distribution of VFs according to capsular serotypes

Two capsular types (A and D) were detected among 28 of the 30 isolates obtained as seen in Tables 5, 6. The majority (76.7%) of the isolates were of capsular type A. The distribution of the capsular types in pneumonic lungs and in apparently health lungs (Table 5) didn't show any statistically significant difference. The distribution of capsular serotypes for each individual isolate is displayed in Table 6.
Table 5

Distribution of capsular serotypes among the isolates.

CapsularOverallPneumonic lungApparently healthy
typesprevalenceisolateslung isolates
(n = 30)(n = 25)(n = 5)
Type A23 (76.7%)18 (72.0%)5 (100.0%)
Type D5 (16.7%)5 (20.0%)
Untyped2 (6.7%)2 (8.0%)
Table 6

Capsular types and virulence genes detected among .

Strain IDCapsule typeVirulence genes
1Type AptfA, fimA, hsf-1, tonB, hgbA, hgbB, Fur, nanB, nanH, pmHAS, ompA, oomph, plpB, soda, sodC
2Type AptfA, fimA, hsf-1, exbD, tonB, hgbA, hgbB, Fur, nanB, nanH, pmHAS, ompA, oomph, oma87, plpB, soda, sodC
3Type AptfA, fimA, hsf-1, tonB, hgbA, hgbB, Fur, nanB, nanH, pmHAS, ompA, oomph, oma87, plpB, soda, sodC, tbpA
4Type DptfA, hsf-2, pfhA, exbB, exbD, hgbA, hgbB, Fur, nanB, nanH, ompA, oomph, oma87, plpB, sodC, tbpA
5Type DptfA, fimA, hsf-2, pfhA, tadD, exbB, hgbA, hgbB, Fur, nanB, nanH, ompA, oomph, oma87, plpB, sodC
6UntypedpfhA, Fur, nanB, nanH, ompA, oomph, oma87, plpB, tbpA
7Type AptfA, fimA, hsf-1, hsf-2, toxA, exbD, tonB, hgbA, hgbB, Fur, nanB, nanH, pmHAS, ompA, oomph, oma87, plpB, sodA, sodC
8Type AptfA, fimA, hsf-1, hsf-2, pfhA, exbB, exbD, tonB, hgbA, hgbB, Fur, nanB, nanH, pmHAS, ompA, oomph, oma87, plpB, soda, sodC, tbpA
9Type AptfA, fimA, hsf-1, hsf-2, pfhA, exbB, exbD, tonB, hgbA, hgbB, Fur, nanB, pmHAS, plpB, ompA, oomph, oma87, soda, sodC, tbpA
10Type AptfA, fimA, exbB, exbD, tonB, hgbA, hgbB, Fur, nanB, pmHAS, ompA, oma87, plpB, soda, sodC, tbpA
11Type DptfA, fimA, hsf-2, pfhA, exbB, exbD, hgbA, hgbB, Fur, nanB, nanH, pmHAS, ompA, oma87, plpB
12Type AptfA, fimA, hsf-2, exbB, exbD, tonB, hgbA, hgbB, pmHAS, oma87, plpB, soda, sodC
13Type AptfA, fimA, hsf-1, hsf-2, pfhA, tadD, exbB, exbD, tonB, hgbA, hgbB, Fur, nanB, ompA, oomph, oma87, plpB, soda, sodC, tbpA
14Type AptfA, fimA, hsf-1, hsf-2, pfhA, tadD, exbB, exbD, tonB, hgbA, hgbB, Fur, nanB, ompA, oomph, oma87, plpB, sodA, sodC, tbpA
15Type AptfA, fimA, hsf-1, hsf-2, exbB, exbD, tonB, hgbA, hgbB, Fur, nanB, nanH, ompA, oomph, oma87, plpB, soda, sodC, tbpA
16Type DptfA, fimA, hsf-2, tadD, exbB, exbD, hgbA, hgbB, Fur, nanB, nanH, pmHAS, ompA, oomph, oma87, plpB, sodA
17Type AptfA, fimA, hsf-2, tadD, exbB, exbD, tonB, hgbB, Fur, nanB, nanH, ompA, oomph, oma87, plpB, soda, sodC, tbpA
18Type AptfA, fimA, hsf-1, pfhA, toxA, exbB, exbD, tonB, hgbB, Fur, nanB, nanH, ompA, oomph, oma87, plpB, soda, sodC, tbpA
19Type AptfA, fimA, hsf-1, hsf-2, pfhA, tadD, exbB, exbD, tonB, hgbB, Fur, nanB, nanH, ompA, oomph, oma87, plpB, soda, sodC, tbpA
20Type AptfA, fimA, hsf-1, hsf-2, toxA, exbB, exbD, tonB, hgbA, hgbB, Fur, nanB, nanH, ompA, oomph, oma87, soda, sodC, tbpA
21UntypedfimA, exbB, hgbA, nanH, ompA, oomph, plpB
22Type AptfA, fimA, hsf-1, hsf-2, pfhA, exbB, exbD, tonB, hgbA, hgbB, Fur, nanB, nanH, ompA, oomph, oma87, plpB, soda, sodC, tbpA
23Type AptfA, fimA, hsf-2, exbB, exbD, tonB, hgbA, hgbB, Fur, nanB, nanH, ompA, oomph, oma87, plpB, soda, sodC, tbpA
24Type AptfA, fimA, hsf-2, pfhA, tadD, exbB, exbD, tonB, hgbA, hgbB, nanB, nanH, ompA, oomph, oma87, plpB, soda, sodC, tbpA
25Type AptfA, fimA, hsf-1, hsf-2, pfhA, tadD, exbB, tonB, hgbA, hgbB, Fur, nanB, nanH, oomph, oma87, plpB, soda, sodC, tbpA
26Type DptfA, hsf-2, pfhA, exbB, hgbA, hgbB, nanB, Fur, ompA, oma87, plpB, soda, sodC
27Type Ahsf-1, hsf-2, pfhA, tadD, exbB, exbD, tonB, hgbA, hgbB, Fur, nanB, nanH, ompA, oomph, oma87, soda, sodC, tbpA
28Type AfimA, hsf-1, hsf-2, pfhA, tadD, exbB, exbD, tonB, hgbA, hgbB, Fur, nanH, oomph, oma87, soda, sodC, tbpA
29Type Ahsf-1, hsf-2, pfhA, tadD, exbB, exbD, tonB, hgbA, hgbB, ompA, nanH, oomph, soda, sodC, tbpA
30Type Ahsf-1, hsf-2, pfhA, tadD, exbB, exbD, tonB, hgbA, hgbB, nanH, ompA, oomph, oma87, soda, sodC
Distribution of capsular serotypes among the isolates. Capsular types and virulence genes detected among .

Distribution of VFs according to associated VF genes

All isolates from pneumonic lungs harbored at least one virulence gene as displayed in Table 7. Table 8 shows the distribution of virulence genes by capsular serotypes. The detected virulence genes for each isolate obtained in this study is presented in Table 6. Most of the adhesins and superoxide dismutases; and all of the iron acquisition and protectin proteins occurred at significantly (p ≤ 0.05) higher frequencies in isolates from pneumonic lungs. One adhesion (hsf-1) and two iron acquisition (exbD and tonB) genes occurred at significantly (p ≤ 0.05) higher frequencies among capA isolates.
Table 7

Distribution of VFs according to associated VF genes.

Virulence genesOverall prevalence (n = 30)Pneumonic lung isolates (n = 25)Apparently healthy lung isolates (n = 5)
ADHESINS
ptfA24 (80.0%)23 (92.0%)1 (20.0%)
fimA24 (80.0%)23 (92.0%)1 (20.0%)
hsf-118 (60.0%)18 (72.0%)
hsf-223 (76.7%)23 (92.0%)
pfhA18 (60.0%)15 (60.0%)3 (60.0%)
tadD12 (40.0%)12 (48.0%)
TOXINS
toxA3 (10.0%)3 (12.0%)
IRON ACQUISITION
exbB25 (83.3%)24 (96.0%)1 (20.0%)
exbD26 (86.7%)25 (100.0%)1 (20.0%)
tonB25 (83.3%)24 (96.0%)1 (20.0%)
hgbA26 (86.7%)25 (100.0%)1 (20.0%)
hgbB28 (93.3%)25 (100.0%)3 (60.0%)
Fur25 (83.3%)24 (96.0%)1 (20.0%)
SIALIDASES nanB
nanB25 (83.3%)25 (100.0%)
nanH24 (80.0%)24 (96.0%)
HYALURONIDASE
pmHAS10 (33.3%)10 (40.0%)
PROTECTINS
ompA27 (90.0%)25 (100.0%)2 (40.0%)
ompH26 (86.7%)25 (100.0%)1 (20.0%)
oma8727 (90.0%)25 (100.0%)2 (40.0%)
plpB25 (83.3%)24 (96.0%)1 (20.0%)
SUPEROXIDE DISMUTASE
sodA25 (83.3%)24 (96.0%)1 (20.0%)
sodC26 (86.7%)25 (100.0%)1 (20.0%)
tbpA20 (66.7%)18 (72.0%)2 (40.0%)
Table 8

Distribution of VFs according to capsule serotypes among 30 bovine isolates of .

Virulence genesOverall (n = 30)capA (n = 23)capD (n = 5)Untyped (n = 2)
ADHESINS
ptfA24 (80.0%)19 (82.6%)5 (100.0%)
fimA24 (80.0%)20 (87.0%)3 (60.0%)1 (50.0%)
hsf-118 (60.0%)18 (78.3%)
hsf-223 (76.7%)18 (78.3%)5 (100.0%)
pfhA18 (60.0%)13 (56.5%)4 (80.0%)1 (50.0%)
tadD12 (40.0%)10 (43.5%)2 (40.0%)
TOXINS
toxA3 (10.0%)3 (13.0%)
IRON ACQUISITION
exbB25 (83.3%)19 (82.6%)5 (100.0%)1 (50.0%)
exbD26 (86.7%)23 (100.0%)3 (60.0%)
tonB25 (83.3%)23 (100.0%)2 (100.0%)
hgbA26 (86.7%)20 (87.0%)5 (100.0%)1 (50.0%)
hgbB28 (93.3%)23 (100.0%)5 (100.0%)
Fur25 (83.3%)19 (82.6%)5 (100.0%)1 (50.0%)
SIALIDASES nanB
nanB25 (83.3%)19 (82.6%)5 (100.0%)1 (50.0%)
nanH24 (80.0%)18 (78.3%)4 (80.0%)2 (100.0%)
HYALURONIDASE
pmHAS10 (33.3%)8 (34.8%)2 (40.0%)
PROTECTINS
ompA27 (90.0%)20 (87.0%)5 (100.0%)2 (100.0%)
ompH26 (86.7%)21 (91.3%)3 (60.0%)2 (100.0%)
oma8727 (90.0%)21 (91.3%)5 (100.0%)1 (50.0%)
plpB25 (83.3%)18 (78.3%)5 (100.0%)2 (100.0%)
SUPEROXIDE DISMUTASE
sodA25 (83.3%)23 (100.0%)2 (40.0%)
sodC26 (86.7%)23 (100.0%)3 (60.0%)
tbpA20 (66.7%)18 (78.3%)1 (20.0%)1 (50.0%)
Distribution of VFs according to associated VF genes. Distribution of VFs according to capsule serotypes among 30 bovine isolates of .

Antimicrobial resistance among the isolates

Antimicrobial resistance profiles of P. multocida isolates obtained in this study are displayed in Table 9. All the isolates were susceptible to ciprofloxacin, co-trimoxazole, doxycycline, enrofloxacin, nitrofurantoin, and tetracyclines. Resistance to ampicillin, lincomycin, penicillin, rifampin, streptomycin, amoxicillin, erythromycin, and florfenicol was observed at different frequencies.
Table 9

Antimicrobial resistance profiles of .

Antimicrobial agentResistant isolatesIntermediate resistant isolatesSusceptible isolates
Ampicillin10 (33.3%)11 (36.7%)9 (30.0%)
Amikacin0 (0.0%)1 (3.3%)29 (96.7%)
Cloramphenicol0 (0.0%)0 (0.0%)29 (96.7%)
Carbenicillin0 (0.0%)1 (3.3%)29 (96.7%)
Ciprofloxacin0 (0.0%)0 (0.0%)30 (100.0%)
Co-trimoxazole0 (0.0%)0 (0.0%)30 (100.0%)
Doxycycline0 (0.0%)0 (0.0%)30 (100.0%)
Enrofloxacin0 (0.0%)0 (0.0%)30 (100.0%)
Gentamicin0 (0.0%)1 (3.3%)29 (96.7%)
Lincomycin13 (43.3%)8 (26.7%)8 (26.7%)
Nitrofurantoin0 (0.0%)0 (0.0%)30 (100.0%)
Oxytetracycline0 (0.0%)0 (0.0%)30 (100.0%)
Penicillin12 (40.0%)9 (30.0%)9 (30.0%)
Rifampin6 (20.0%)6 (20.0%)18 (60.0%)
Streptomycin5 (16.7%)0 (0.0%)25 (83.3%)
Tetracycline0 (0.0%)0 (0.0%)30 (100.0%)
Amoxicillin3 (10.0%)3 (10.0%)24 (80.0%)
Erythromycin10 (33.3%)10 (33.3%)10 (33.3%)
Kanamycin0 (0.0%)4 (13.3%)26 (86.7%)
Florfenicol5 (16.7%)6 (20.0%)19 (63.3%)
Antimicrobial resistance profiles of .

Discussion

VFs play a key role in disease production by bacterial pathogens (Nanduri et al., 2009). Among others, their functions include competence, adherence, synthesis, and export of capsules; and evasion of host immune responses (Nanduri et al., 2009). In the present study the factors have been detected in P. multocida isolated from the lungs of slaughter cattle. The higher frequency of the factors among isolates from pneumonic lungs suggests the role of these factors in disease occurrence. It was pointed out that virulence gene occurrence in P. multocida has a strong positive association with the outcome of infection with the organism in cattle (Katsuda et al., 2013). On the other hand occurrence of the factors in apparently healthy lungs could possibly indicate early infection or contained infection which couldn't lead to disease. It was previously reported that this facultative anaerobic bacterium is commonly found in clinically healthy calves (Lainson et al., 2013). In this study capsular types A and D were detected using PCR among the obtained P. multocida isolates. A small proportion (6.7%; 2/30) of P. multocida strains were untypeable, a similar observation to what was reported by Arumugam et al. (2011). Capsular type A was predominant among the strains accounting for 76.6%. Our observation is similar to a finding by Katsuda et al. (2013) who also detected capsular types A and D among cattle derived P. multocida isolates; with type A occurring at higher frequency. A higher frequency of capsular type A among cattle derived P. multocida isolates has also been reported in a study conducted earlier by Davies et al. (2004) who found that 99.3% of bovine P. multocida strains (n = 153) were of this capsular type. P. multocida isolates of serotype A are common in bovids occurring as normal flora in the nasopharynx; or as causes of disease including BRD and hemorraghic septicemia (Ewers et al., 2004; Dabo et al., 2007). The capsular type A is also most frequently described for rabbits (Ewers et al., 2006) and pigs (García et al., 2011). Of the protectins; OmpA and oma87 were the most frequently detected genes particularly in the isolates from pneumonic lungs. Slightly higher frequencies of the two genes were noted for isolates of the capA serogroup than those belonging to the capD serogroup. The OmpA gene has a significant role in stabilizing the cell envelope structure by providing physical linkage between the outer membrane and peptidoglycan (Katoch et al., 2014). It mediates P. multocida host cells interaction through heparin and/or fibronectin binding and thus acts as an important invasive molecule which could determine the outcome of infection with the organism (Katoch et al., 2014). The type 4 fimbria (ptfA gene) was described in 92.0% of the isolates tested in the current study. The gene plays a key role of fixing bacterial pathogens on the surface of the epithelial cells of hosts, a phenomenon which is more common in rabbits (Ewers et al., 2006). Consequently a study conducted on rabbits described a high prevalence of the ptfA gene (93.4%; 43/46). Presence of adhesins on the bacterial surface is usually linked to virulence as these proteins are known to play a crucial role in facilitating host invasion and colonization (Kline et al., 2009). Studies by Ewers et al. (2000) and Tang et al. (2009) have demonstrated that, of the adhesins; fimA, hsf-2, and ptfA are of frequent occurrence among pathogenic isolates of P. multocida. In the current study the three adhesins were demonstrated at higher frequencies than others in both capA and capD serogroup isolates. On the other hand, gene tadD was the least frequently detected adhesin among P. multocida, occurring only in 48.0% of the isolates (n = 30). In these organisms the gene is known to be a putative non-specific tight adherence protein D (May et al., 2001). A more or less similar low frequency (43.3%; 100/233) of tadD was described in a field study involving pigs (Tang et al., 2009). A work on rabbits, however, observed a higher frequency (91.3%; 42/46) of this gene among P. multocida strains. It is noteworthy that the dermonecrotoxin encoding toxA was the least frequently detected gene among the isolates; demonstrated only in those of capsular type A obtained from pneumonic lungs. Some other researchers indicated that this particular gene is more frequently expressed by strains of serogroup D and is responsible for the clinical symptoms associated with atrophic rhinitis in porcines (Harper et al., 2006; Ferreira et al., 2012). The observation in the current study could be attributed to the small sample size of capsular type D isolates. In a study conducted earlier the gene was detected in P. multocida isolates from avians, swine, shoats and cattle; but was only associated with disease in pigs (Ewers et al., 2006). Pullinger et al. (2004) points out that the toxA gene is not inserted into the bacterial chromosome but in a lysogenic bacteriophage that infects the agent. The tbpA encoding gene is known to be of common occurrence among ruminant P. multocida strains (Ewers et al., 2006; Atashpaz et al., 2009). Its prevalence was however relatively low when compared to other superoxide dismutases (sodA and sodC) tested in this study. Ferreira et al. (2012) found a low frequency (8.6%; 4/46) of this gene in a study conducted on rabbits. Variable frequencies of the genes encoding proteins with different functions, such as adhesins (fimA, hsf-1, hsf-2, and pfhA), iron acquisition (exbB, exbD, tonB, hgbA, hgbB, and Fur), sialidases (nanB and nanH), hyaluronidase (pmHAS), and protectins (oomph and plpB) were found in the isolates. This finding is similar to what was reported in previous works which involved ruminants, porcine, poultry, and rabbits (Ewers et al., 2006; Tang et al., 2009; Ferreira et al., 2012). Infections with P. multocida are commonly managed by broad-spectrum antimicrobials (Kehrenberg et al., 2001; Lion et al., 2006; Brogden et al., 2007). Studies have however reported occurrence of resistance to a large number of antimicrobial agents among P. multocida isolates (Hunt et al., 2001; Davies et al., 2004; Arashima and Kumasaka, 2005). In the current study all the P. multocida isolates were susceptible to ciprofloxacin, co-trimoxazole, doxycycline, enrofloxacin, nitrofurantoin, and tetracyclines. Similar observations for ciprofloxacin and co-trimoxazole (Mohamed et al., 2012); and for enrofloxacin, tetracycline, and doxycycline (Ferreira et al., 2012) have also been made earlier. These antibiotics can therefore be used for prevention and treatment of bovine P. multocida infections in the study area. Unlike other authors who reported poor (Gutiérrez Martin and Rodríguez Ferri, 1993; Yoshimura et al., 2001) and moderate (Mohamed et al., 2012) activity of aminoglycoside antibiotics against P. multocida, in the present study kanamycin, gentamicin, amikacin, and streptomycin exhibited high activity against the tested isolates. The frequencies of resistant isolates to other antibiotics varied greatly as reported by other researchers (Salmon et al., 1995; Kehrenberg et al., 2001; Yoshimura et al., 2001; Welsh et al., 2004). The major limitation in the discussion of the findings of the current study was large differences in the sample sizes of comparison groups as seen for isolates between isolates from pneumonic lungs and those from apparently health lungs; and isolates of different capsular types. This made it difficult to infer on the observed variations as they could be attributed to chance. In summary, our results reveal presence of VFs in P. multocida strains isolated from the lungs of symptomatic and asymptomatic slaughter cattle. Frequent detection of the factors among isolates from symptomatic study animals may suggest their role in pathogenesis of BRD caused by these organisms. Occurrence of antimicrobial resistance among some isolates is of great concern. Control strategies for this pathogen, which could include development of an effective vaccine, are warranted so as to mitigate the social and economic consequences attributable to natural infections with this bacterium. Further, the use of antimicrobial agents in modern livestock farming need to be controlled so as to minimize the emergence and eventually spread of resistance not only in target microbes but also in other important zoonotic pathogens.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  49 in total

1.  Studies on Pasteurella multocida. I. A hemagglutination test for the identification of serological types.

Authors:  G R CARTER
Journal:  Am J Vet Res       Date:  1955-07       Impact factor: 1.156

2.  The challenge of antibiotic resistance.

Authors:  S B Levy
Journal:  Sci Am       Date:  1998-03       Impact factor: 2.142

3.  Complete genomic sequence of Pasteurella multocida, Pm70.

Authors:  B J May; Q Zhang; L L Li; M L Paustian; T S Whittam; V Kapur
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

4.  In vitro and in vivo pathogenicity studies of Pasteurella multocida strains harbouring different ompA.

Authors:  Shailja Katoch; Mandeep Sharma; R D Patil; Sandeep Kumar; Subhash Verma
Journal:  Vet Res Commun       Date:  2014-03-07       Impact factor: 2.459

5.  A ten-year (2000-2009) study of antimicrobial susceptibility of bacteria that cause bovine respiratory disease complex--Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni--in the United States and Canada.

Authors:  Ellen Portis; Cynthia Lindeman; Lacie Johansen; Gillian Stoltman
Journal:  J Vet Diagn Invest       Date:  2012-09       Impact factor: 1.279

Review 6.  Pasteurella multocida infections. II. Pasteurella multocida infection in man unrelated to animal bite.

Authors:  W T Hubbert; M N Rosen
Journal:  Am J Public Health Nations Health       Date:  1970-06

7.  Rapid virulence typing of Pasteurella multocida by multiplex PCR.

Authors:  Sina Atashpaz; Jalal Shayegh; Mohammad Saied Hejazi
Journal:  Res Vet Sci       Date:  2009-05-02       Impact factor: 2.534

8.  Comparison of MICs of ceftiofur and other antimicrobial agents against bacterial pathogens of swine from the United States, Canada, and Denmark.

Authors:  S A Salmon; J L Watts; C A Case; L J Hoffman; H C Wegener; R J Yancey
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

9.  The transcriptional response of Pasteurella multocida to three classes of antibiotics.

Authors:  Bindu Nanduri; Leslie A Shack; Shane C Burgess; Mark L Lawrence
Journal:  BMC Genomics       Date:  2009-07-14       Impact factor: 3.969

10.  Draft Genome Sequence of Pasteurella multocida A:3 Strain 671/90.

Authors:  Frederick A Lainson; Mark P Dagleish; Michael C Fontaine; Colin Bayne; J Christopher Hodgson
Journal:  Genome Announc       Date:  2013-10-03
View more
  11 in total

Review 1.  Pasteurella multocida: Genotypes and Genomics.

Authors:  Zhong Peng; Xiangru Wang; Rui Zhou; Huanchun Chen; Brenda A Wilson; Bin Wu
Journal:  Microbiol Mol Biol Rev       Date:  2019-09-04       Impact factor: 11.056

2.  Virulence Determinants and Antimicrobial Profiles of Pasteurella multocida Isolated from Cattle and Humans in Egypt.

Authors:  Mohamed Sabry Abd Elraheam Elsayed; Samah Mahmoud Eldsouky; Tamer Roshdy; Lamia Said; Nahed Thabet; Tamer Allam; A B Abeer Mohammed; Ghada M Nasr; Mohamed S M Basiouny; Behiry A Akl; Maha M Nader; Al Shaimaa Hasan; Ahmed Salah
Journal:  Antibiotics (Basel)       Date:  2021-04-22

3.  OmpA protein sequence-based typing and virulence-associated gene profiles of Pasteurella multocida isolates associated with bovine haemorrhagic septicaemia and porcine pneumonic pasteurellosis in Thailand.

Authors:  Teerasak E-Kobon; Ratiporn Leeanan; Saengtian Pannoi; Pornchai Anuntasomboon; Pacharee Thongkamkoon; Arinthip Thamchaipenet
Journal:  BMC Vet Res       Date:  2017-08-16       Impact factor: 2.741

4.  Infection of bovine well-differentiated airway epithelial cells by Pasteurella multocida: actions and counteractions in the bacteria-host interactions.

Authors:  Ang Su; Jie Tong; Yuguang Fu; Sandy Müller; Yenehiwot Berhanu Weldearegay; Paul Becher; Peter Valentin-Weigand; Jochen Meens; Georg Herrler
Journal:  Vet Res       Date:  2020-11-23       Impact factor: 3.683

5.  Serotyping, Genotyping and Virulence Genes Characterization of Pasteurella multocida and Mannheimia haemolytica Isolates Recovered from Pneumonic Cattle Calves in North Upper Egypt.

Authors:  Ahmed H Abed; Fawzy R El-Seedy; Hany M Hassan; Ashraf M Nabih; Eman Khalifa; Salwa E Salem; Gamal Wareth; Ahmed M S Menshawy
Journal:  Vet Sci       Date:  2020-11-10

6.  Novel multi-strain probiotics reduces Pasteurella multocida induced fowl cholera mortality in broilers.

Authors:  Rine Christopher Reuben; Shovon Lal Sarkar; Habiba Ibnat; Md Ali Ahasan Setu; Pravas Chandra Roy; Iqbal Kabir Jahid
Journal:  Sci Rep       Date:  2021-04-26       Impact factor: 4.379

7.  Development of an Online Tool for Pasteurella multocida Genotyping and Genotypes of Pasteurella multocida From Different Hosts.

Authors:  Zhong Peng; Junyang Liu; Wan Liang; Fei Wang; Li Wang; Xueying Wang; Lin Hua; Huanchun Chen; Brenda A Wilson; Jia Wang; Bin Wu
Journal:  Front Vet Sci       Date:  2021-12-17

8.  Comparative Genomics Analyses Support the Reclassification of Bisgaard Taxon 40 as Mergibacter gen. nov., With Mergibacter septicus sp. nov. as Type Species: Novel Insights Into the Phylogeny and Virulence Factors of a Pasteurellaceae Family Member Associated With Mortality Events in Seabirds.

Authors:  Eliana De Luca; Sonsiray Álvarez-Narváez; Grazieli Maboni; Rodrigo P Baptista; Nicole M Nemeth; Kevin D Niedringhaus; Jason T Ladner; Jeffrey M Lorch; Galina Koroleva; Sean Lovett; Gustavo F Palacios; Susan Sanchez
Journal:  Front Microbiol       Date:  2021-11-22       Impact factor: 5.640

9.  Pasteurella multocida capsular: lipopolysaccharide types D:L6 and A:L3 remain to be the main epidemic genotypes of pigs in China.

Authors:  Songtao Liu; Lin Lin; Hao Yang; Wenqing Wu; Long Guo; Yue Zhang; Fei Wang; Xueying Wang; Wenbo Song; Lin Hua; Wan Liang; Xibiao Tang; Huanchun Chen; Zhong Peng; Bin Wu
Journal:  Anim Dis       Date:  2021-11-02

10.  Investigation of iron uptake and virulence gene factors (fur, tonB, exbD, exbB, hgbA, hgbB1, hgbB2 and tbpA) among isolates of Pasteurella multocida from Iran.

Authors:  Motahare Feizabadi Farahani; Majid Esmaelizad; Ahmad Reza Jabbari
Journal:  Iran J Microbiol       Date:  2019-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.